Boehringer Ingelheim has concluded phase one of their localization effort aimed at manufacturing their innovative thrombolytic medicines in Russia: the first batches of Metalyse (tenectaplase) for acute heart attack treatment were produced at NPO Petrovax Pharm facilities.

By the end of 2019, the companies intend to complete the transfer of technologies and to launch full-cycle production of innovative thrombolytic medicines at Petrovax Pharm’s production facility in the Moscow Region.

This year good snow cover may allow ski runs to open as early as the middle of December. For the new season, the ski resort has significantly extended its ski runs, from 77 to 94 kilometers, and put three new cable cars into service.

Rosa Khutor won the prestigious «Leader of the sports Industry Award» with 33,6% of voices received from the processional and peoples’ jury.

According to Rosa Khutor general Director Sergey Bachin, «in 2015 winter season, Rosa Khutor hosted 600 thousand tourists and 750 thousand in summer season, this gives us a total of 1.35 mln guests in 2015. In 2016 winter season, the number of visitors reached 800 thousand, it’s a 30% increase compared to the previous winter season. We expect that in 2016 the total number of tourists will reach 1.5 mln».